Two Bevacizumab-Based Combination Regimens Equally Effective In Patients With Metastatic - Congoo

|

|

News

Media & Advertising

WORLD

Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic

Have an interest in this Story?
Sign Up for Real-Time email updates

Doctors Guide | July 03, 2009

-- Combining bevacizumab (BEV) with capecitabine plus irinotecan (XELIRI) is an effective alternative to BEV plus 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in patients with metastatic colorectal cancer (mCRC), researchers reported here at the 11th World Gastrointestinal Cancer Cong...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Headley is my brother: Gilani PRO - Deccan Chronicle

China announces targets on carbon emission cuts - China Mining

AICC, NCP wary of Smita Thackerays offer - Indian Express

Terrorism suspected in Russian train crash - Telegraph

City targets ex-NBA star Walker for 'slum' housing - Chicago Tribune

Featured Members

Matthew Clark
Mentor
Entrepreneur

Martin P. Lee
Associate Lecturer
Knowledge Management

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2009 Congoo.com. All Rights Reserved.